| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in PTCT over the last quarter tilts toward selling: insiders offloaded a net 112,078 shares worth roughly $7.8M. In the past 30 days, 0 insiders bought and 2 sold.
Both insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.29M | $89.56M | -5,000 | |
| CEO | 383.9K | $26.62M | - | |
| VP | 105.3K | $7.30M | -627 | |
| CFO | 84.0K | $5.82M | - | |
| VP | 79.1K | $5.49M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | Mark Elliott Boulding56 | Executive VP and CLO | Sale+OE10b5-1 | 2,813 | $48.58 | $136,655.54 | -2.6% | +53.5% | +46.9% | |
| Aug 5, 2025 | Matthew B. Klein53 | Chief Executive Officer | Sell10b5-1 | 10,739 | $51.74 | $555,635.86 | -3.1% | +32.9% | +35.4% | |
| Jul 15, 2025 | Pierre Gravier55 | Chief Financial Officer | Sell10b5-1 | 2,516 | $49.46 | $124,441.36 | -3.4% | +38.3% | +65.1% | |
| May 16, 2025 | Mark Elliott Boulding56 | Executive VP and CLO | Sale+OE | 2,812 | $46.13 | $129,716.88 | -2.6% | +5.8% | +55.3% | |
| Apr 22, 2025 | Matthew B. Klein53 | Chief Executive Officer | Sell10b5-1 | 2,804 | $48.74 | $136,655.74 | -1.0% | -0.7% | - | |
| Apr 2, 2025 | Lee Scott Golden | EVP & Chief Medical Officer | Sell10b5-1 | 897 | $46.95 | $42,114.15 | -1.2% | +0.5% | +40.1% | |
| Mar 17, 2025 | Eric Pauwels61 | Chief Business Officer | Sell10b5-1 | 11,220 | $56.16 | $630,104.40 | -13.4% | -9.3% | +18.0% | |
| Mar 13, 2025 | Stephanie Okey55 | Director | Sell | 5,000 | $54.00 | $270,000.00 | -36.1% | -3.7% | +22.2% | |
| Mar 12, 2025 | Mark Elliott Boulding56 | Executive VP and CLO | Sale+OE10b5-1 | 15,521 | $53.30 | $827,232.91 | -13.0% | -3.5% | +18.2% | |
| Mar 11, 2025 | Mark Elliott Boulding56 | Executive VP and CLO | Sale+OE10b5-1 | 75,420 | $53.08 | $4,003,304.97 | -42.1% | -1.7% | +24.9% |